1. Home
  2. RNA vs LBTYA Comparison

RNA vs LBTYA Comparison

Compare RNA & LBTYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • LBTYA
  • Stock Information
  • Founded
  • RNA 2012
  • LBTYA 2004
  • Country
  • RNA United States
  • LBTYA Bermuda
  • Employees
  • RNA N/A
  • LBTYA N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • LBTYA Cable & Other Pay Television Services
  • Sector
  • RNA Health Care
  • LBTYA Telecommunications
  • Exchange
  • RNA Nasdaq
  • LBTYA Nasdaq
  • Market Cap
  • RNA 4.4B
  • LBTYA 4.7B
  • IPO Year
  • RNA 2020
  • LBTYA N/A
  • Fundamental
  • Price
  • RNA $32.74
  • LBTYA $12.38
  • Analyst Decision
  • RNA Strong Buy
  • LBTYA Buy
  • Analyst Count
  • RNA 10
  • LBTYA 8
  • Target Price
  • RNA $63.60
  • LBTYA $21.70
  • AVG Volume (30 Days)
  • RNA 1.1M
  • LBTYA 2.6M
  • Earning Date
  • RNA 11-07-2024
  • LBTYA 10-29-2024
  • Dividend Yield
  • RNA N/A
  • LBTYA N/A
  • EPS Growth
  • RNA N/A
  • LBTYA N/A
  • EPS
  • RNA N/A
  • LBTYA N/A
  • Revenue
  • RNA $10,117,000.00
  • LBTYA $7,674,500,000.00
  • Revenue This Year
  • RNA N/A
  • LBTYA $2.89
  • Revenue Next Year
  • RNA N/A
  • LBTYA N/A
  • P/E Ratio
  • RNA N/A
  • LBTYA N/A
  • Revenue Growth
  • RNA N/A
  • LBTYA 3.53
  • 52 Week Low
  • RNA $8.37
  • LBTYA $10.93
  • 52 Week High
  • RNA $56.00
  • LBTYA $21.56
  • Technical
  • Relative Strength Index (RSI)
  • RNA 30.43
  • LBTYA 27.02
  • Support Level
  • RNA $32.04
  • LBTYA $12.56
  • Resistance Level
  • RNA $34.35
  • LBTYA $13.15
  • Average True Range (ATR)
  • RNA 2.07
  • LBTYA 0.34
  • MACD
  • RNA -0.55
  • LBTYA 0.13
  • Stochastic Oscillator
  • RNA 6.24
  • LBTYA 0.00

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.

About LBTYA Liberty Global Ltd.

Liberty Global is a holding company with interests in several telecom companies in the U.K., Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty is the owner of the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile-network-operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.

Share on Social Networks: